Skip to main content
Carelabs Co.,Ltd logo

Carelabs Co.,Ltd — Investor Relations & Filings

Ticker · 263700 ISIN · KR7263700007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 455 across all filing types
Latest filing 2022-07-29 Regulatory Filings
Country KR South Korea
Listing KO 263700

About Carelabs Co.,Ltd

https://www.carelabs.co.kr/

Carelabs Co., Ltd. is a platform company that provides comprehensive IT services for the healthcare and beauty care sectors. The company develops and operates solutions aimed at creating a more convenient and accessible healthcare ecosystem by resolving imbalances in medical information. Its core services include specialized customer relationship management (CRM) software for hospitals, such as 'SmartCRM' and 'UnoCRM', which support patient management and marketing activities. Additionally, Carelabs offers performance-based digital marketing services tailored to clients in the medical field. Through its technology-driven platforms, the company facilitates online-to-offline (O2O) connections within the health and beauty markets.

Recent filings

Filing Released Lang Actions
본점소재지변경
Regulatory Filings Classification · 100% confidence The document is a short, formal announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details about the old and new addresses, the reason for the change, and the effective date. Since this is a regulatory disclosure regarding corporate administrative changes that does not fit into specific financial reporting categories like 10-K, IR, or ER, it falls under the general regulatory filing category.
2022-07-29 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report), which is the Korean equivalent of an Annual Report (10-K). It contains detailed company information, financial data, management discussion, and governance details for the fiscal year 2021. Although it is labeled as a '정정신고' (Correction Report), it is a comprehensive filing that includes the full annual report content, not just a notification of a report. FY 2021
2022-07-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in share ownership (specifically a 1% or more change) by Focus Asset Management in Carelabs. This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds.
2022-07-13 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Carelabs) regarding the adjustment of the conversion price of convertible bonds (CB). It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2022-07-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details changes in share ownership, specifically regarding collateral agreements and major shareholding status. In the context of global financial reporting, this falls under the 'Major Shareholding Notification' category, as it tracks significant ownership thresholds and changes in control.
2022-07-04 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Carelabs) regarding a 'Correction Report' (정정신고) for a 'Stock Collateral Provision Agreement' (주식 담보제공 계약). It details changes in collateralized shares, creditor information, and debt terms. This type of disclosure regarding capital structure and share pledging is classified under 'Regulatory Filings' as it is a specific corporate disclosure required by the exchange that does not fit into the other specialized categories like M&A, Earnings, or Dividends.
2022-06-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.